JPH0430824B2 - - Google Patents
Info
- Publication number
- JPH0430824B2 JPH0430824B2 JP62245875A JP24587587A JPH0430824B2 JP H0430824 B2 JPH0430824 B2 JP H0430824B2 JP 62245875 A JP62245875 A JP 62245875A JP 24587587 A JP24587587 A JP 24587587A JP H0430824 B2 JPH0430824 B2 JP H0430824B2
- Authority
- JP
- Japan
- Prior art keywords
- food
- present
- dietary fiber
- gel
- protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 235000013305 food Nutrition 0.000 claims description 46
- 235000013325 dietary fiber Nutrition 0.000 claims description 20
- 102000004169 proteins and genes Human genes 0.000 claims description 18
- 108090000623 proteins and genes Proteins 0.000 claims description 18
- 235000018102 proteins Nutrition 0.000 claims description 10
- 235000021245 dietary protein Nutrition 0.000 claims description 8
- 239000000679 carrageenan Substances 0.000 claims description 6
- 235000010418 carrageenan Nutrition 0.000 claims description 6
- 229920001525 carrageenan Polymers 0.000 claims description 6
- 229940113118 carrageenan Drugs 0.000 claims description 6
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical group [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 6
- 230000002378 acidificating effect Effects 0.000 claims description 5
- 239000005018 casein Substances 0.000 claims description 3
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 3
- 235000021240 caseins Nutrition 0.000 claims description 3
- 150000003839 salts Chemical class 0.000 claims description 3
- 239000008280 blood Substances 0.000 description 18
- 210000004369 blood Anatomy 0.000 description 18
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 12
- 210000002784 stomach Anatomy 0.000 description 11
- 230000000694 effects Effects 0.000 description 8
- 239000012530 fluid Substances 0.000 description 8
- 235000008429 bread Nutrition 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 102000004877 Insulin Human genes 0.000 description 6
- 108090001061 Insulin Proteins 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 6
- 230000002496 gastric effect Effects 0.000 description 6
- 229940125396 insulin Drugs 0.000 description 6
- 108010076119 Caseins Proteins 0.000 description 5
- 102000011632 Caseins Human genes 0.000 description 5
- 206010020710 Hyperphagia Diseases 0.000 description 5
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 235000020830 overeating Nutrition 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 4
- 239000000796 flavoring agent Substances 0.000 description 4
- 235000019634 flavors Nutrition 0.000 description 4
- 235000011194 food seasoning agent Nutrition 0.000 description 4
- 235000012054 meals Nutrition 0.000 description 4
- 239000004278 EU approved seasoning Substances 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 230000000968 intestinal effect Effects 0.000 description 3
- 230000000291 postprandial effect Effects 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 229940080237 sodium caseinate Drugs 0.000 description 3
- 235000013599 spices Nutrition 0.000 description 3
- 208000024891 symptom Diseases 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 235000016623 Fragaria vesca Nutrition 0.000 description 2
- 235000011363 Fragaria x ananassa Nutrition 0.000 description 2
- 230000036528 appetite Effects 0.000 description 2
- 235000019789 appetite Nutrition 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000002641 glycemic effect Effects 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000000638 stimulation Effects 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 244000307700 Fragaria vesca Species 0.000 description 1
- 240000009088 Fragaria x ananassa Species 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- 206010018429 Glucose tolerance impaired Diseases 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 244000246386 Mentha pulegium Species 0.000 description 1
- 235000016257 Mentha pulegium Nutrition 0.000 description 1
- 235000004357 Mentha x piperita Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 208000017442 Retinal disease Diseases 0.000 description 1
- 206010038923 Retinopathy Diseases 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 235000010724 Wisteria floribunda Nutrition 0.000 description 1
- 239000003472 antidiabetic agent Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 108010033929 calcium caseinate Proteins 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000001934 delay Effects 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 235000012041 food component Nutrition 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 210000004051 gastric juice Anatomy 0.000 description 1
- 238000001879 gelation Methods 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 235000001050 hortel pimenta Nutrition 0.000 description 1
- 229940126904 hypoglycaemic agent Drugs 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000018984 mastication Effects 0.000 description 1
- 238000010077 mastication Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000012794 white bread Nutrition 0.000 description 1
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62245875A JPH0191759A (ja) | 1987-10-01 | 1987-10-01 | ゲル状食品 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62245875A JPH0191759A (ja) | 1987-10-01 | 1987-10-01 | ゲル状食品 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH0191759A JPH0191759A (ja) | 1989-04-11 |
| JPH0430824B2 true JPH0430824B2 (de) | 1992-05-22 |
Family
ID=17140105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62245875A Granted JPH0191759A (ja) | 1987-10-01 | 1987-10-01 | ゲル状食品 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0191759A (de) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6229947A (ja) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | 難消化性多糖含有ゲルの製造法 |
-
1987
- 1987-10-01 JP JP62245875A patent/JPH0191759A/ja active Granted
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6229947A (ja) * | 1985-07-31 | 1987-02-07 | Ajinomoto Co Inc | 難消化性多糖含有ゲルの製造法 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPH0191759A (ja) | 1989-04-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US6468962B1 (en) | Nutritional intervention composition for enhancing and extending satiety | |
| US20220125093A1 (en) | Nutritional supplements including meal replacements and related methods | |
| PT1588629E (pt) | Composição que contém pectina para formar uma matriz | |
| JP2006503105A (ja) | ロイシンに富んだ栄養的組成物 | |
| CA2379180C (en) | Methods for suppressing appetite and enhancing exercise and recovery | |
| NO763970L (de) | ||
| WO1988001477A1 (en) | Food composition | |
| US6905702B1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
| ZA200308672B (en) | Method and composition for prophylaxis of diabetes. | |
| JPS60188403A (ja) | 組成物 | |
| CN112535729B (zh) | 一种具有防治透析患者并发症功效的组合物及其制备方法和其应用 | |
| JP2006503099A (ja) | カロリー摂取量を低減する組成物 | |
| Smith et al. | Enteral nutrition support: Formula preparation from modular ingredients | |
| JP2000189109A (ja) | 液状食品 | |
| WO2001033976A1 (en) | Methods for regulating blood glucose and appetite suppression in type 2 diabetics | |
| EP1712139A1 (de) | Zusammensetzung mit verlängerter Energiefreisetzung | |
| JP3165743B2 (ja) | 液状食品 | |
| Zillikens et al. | Effects of the glucosidase inhibitor acarbose in patients with liver cirrhosis | |
| JPH0430824B2 (de) | ||
| JPH0364098B2 (de) | ||
| JP2001233783A (ja) | 術前栄養剤 | |
| WO1998054985A1 (en) | Product and method for providing glutamine | |
| WO1995017199A1 (en) | Novel therapeutic carbohydrate blends useful for aiding sleep disorders | |
| Reif-Lehrer | Adverse Reactions in Humans thought to be Related to Ingestion of Elevated Levels of Free Monosodium Glutamate (MSG) Chinese Restaurant Syndrome and Other Reactions | |
| Lagua | I. Chemical symbol for iodine. Iatrogenic. Tenn meaning" caused by medical treatment or diagnostic proce-dures." Iatrogenic malnutrition is an in-duced nutritional deficiency due to drug |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| LAPS | Cancellation because of no payment of annual fees |